Optimising on-treatment review schedules: A narrative review of acute toxicities in ultra-hypofractionated stereotactic ablative body radiotherapy (SABR) for localised prostate cancer
Understanding the timing and pattern of acute toxicities can support radiotherapy teams in designing evidence-based review schedules, improving early detection of side effects, guiding patient education, and ensuring timely symptom management during SABR pathways.
Authors
- G. McKenna
- T. Flood
Institutions
- University of Ulster (GB)
- The Northern Ireland Cancer Centre (GB)
Publication Details
- Journal
- Radiography
- Published
- 2026-02-17
- DOI
- https://doi.org/10.1016/j.radi.2026.103357
- Primary Topic
- Prostate Cancer Diagnosis and Treatment
- Type
- article
- Field-Weighted Citation Impact
- 0.00